PATENT CLAIM ANALYSIS

Application Number: 16032270
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "400000"]

Abstract:
Injectable depot compositions, comprising a biocompatible polymer which is a polymer or copolymer based on lactic acid and/or lactic acid plus glycolic acid having a monomer ratio of lactic to glycolic acid in the range from 48:52 to 100:0, a water-miscible solvent having a dipole moment of about 3.7-4.5 D and a dielectric constant of between 30 and 50, and a drug, were found suitable for forming in-situ biodegradable implants which can evoke therapeutic drug plasma levels from the first day and for at least 14 days.

Claim (Index 5):
The method of  claim 1 , wherein the injectable depot composition is administered intramuscularly, intraperitoneally, intrathecally, intravaginally, subcutaneously, intracranially or intracerebrally.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 95.0
- Lexical Diversity: 1.4375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13690707', '15944894', '13690647', '14555287', '14610362']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.807195563674256
- 35 USC 102 Novelty (BERT): 0.647285325444087
- Combined Prediction Score: 0.7912045398512392
- Mean Citation Score: 493.552822
- Max Citation Score: 740.9466
- Similarity Product: 565.6194366578579

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test